Prof. Dr. Vicente Vanaclocha | Medicine | Lifetime achievement Award

Full Professor, University of Valencia, Spain

Dr. Vicente Vanaclocha-Vanaclocha is a renowned Spanish neurosurgeon with over four decades of clinical and academic experience. Recognized for his dedication to advancing neurosurgical techniques, he serves as a Consultant Neurosurgeon at Consorcio Hospital General Universitario de Valencia and a Professor of Neurosurgery at the University of Valencia. Known for his work in spine surgery, brain tumors, and peripheral nerves, he remains an influential figure in both national and international neurosurgical communities.

🎓 Education Background:

Dr. Vanaclocha began his medical journey at the School of Medicine, Universidad de Valencia (1977–1982), earning his MD degree. He completed his neurosurgery specialization at Hospital Clínico Universitario de Valencia (1983–1987) and pursued a PhD in Neurosurgery from Universidad de Valencia, awarded in 1988. In addition to his medical training, he holds advanced language qualifications: C1 German from Goethe Institut, C1 English from the University of Cambridge, and C2 Català from Junta Qualificadora de Coneiximents de Valencia.

💼 Professional Experience:

His illustrious career includes leadership roles such as Head of Neurosurgery at Clinica Universidad de Navarra (1989–1999) and Consorcio Hospital General Universitario de Valencia (2011–2015). He has also practiced at international institutions, including Groote Schuur Hospital in South Africa (1988–1989), enriching his global neurosurgical perspective. He continues to work in private practice at Hospital Vithas Valencia 9 de Octubre and has previous experience in other prominent hospitals across Spain.

🏅 Awards and Honors:

Dr. Vanaclocha is a respected member of prestigious professional societies, including the American Association of Neurological Surgeons (AANS) since 2017, North American Spine Society (NASS) since 2009, European Association of Neurosurgical Societies (EANS) since 1989, and Sociedad Española de Neurocirugía (SENEC) since 1987. His extensive memberships reflect international recognition of his professional contributions.

🔬 Research Focus:

His research interests span neurosurgery with a specific focus on sacroiliac joint pain, spinal biomechanics, peripheral nerve regeneration, and brain tumor treatment. His recent studies emphasize innovations in implant design, spinal motion preservation, and cerebrospinal fluid management in hemorrhagic conditions.

Dr. Lova Kajuluri | Medicine | Best Researcher Award

Postdoctoral Research Fellow, Mass General Brigham, United States

Lova Prasadareddy Kajuluri is a Postdoctoral Research Fellow at the Cardiovascular Research Center, Massachusetts General Hospital (MGH), Charlestown, USA. He is recognized for his significant contributions to cardiovascular research, particularly in understanding vascular calcification and its potential treatments. With a strong background in biotechnology, Kajuluri has advanced in his research career through various prestigious roles in both India and the United States. He holds a Doctorate in Science from the CSIR-Central Drug Research Institute, Lucknow, India, and has received multiple research grants to further his studies in cardiovascular diseases. 🚀

Publication Profile

Education Background

Kajuluri’s educational journey began with a Bachelor of Science in Biotechnology, Biochemistry, and Chemistry from Andhra University in 2007. He continued to pursue a Master of Science in Biotechnology from Andhra University, followed by a Ph.D. in Science from CSIR-Central Drug Research Institute, India. His academic excellence has paved the way for several postdoctoral positions, starting from his research fellowship at Boston University to his current position at Massachusetts General Hospital, where he continues to explore novel therapies in cardiovascular research. 🎓📚

Professional Experience

Kajuluri’s professional career began as a Research Fellow at CSIR-Central Drug Research Institute in India, focusing on Leishmaniasis and actin-related proteins. He transitioned to postdoctoral research at Boston University, where he led studies on vascular smooth muscle contraction and calponin. His current role as a Postdoctoral Research Fellow at MGH involves leading studies on vascular calcification, gene therapy, and identifying therapeutic targets to treat cardiovascular diseases. His extensive research in these areas contributes significantly to the advancement of vascular health. 🔬🧑‍🔬

Awards and Honors

Kajuluri has received numerous prestigious awards throughout his career. Notably, he was awarded the Research Fellowship from the University Grants Commission, New Delhi, India (2011-2016). He has also been a part of several funded research projects, including those supported by the National Heart, Lung, and Blood Institute, USA. His dedication to advancing cardiovascular and infectious disease research has earned him recognition from the scientific community. 🏆🎖️

Research Focus

Kajuluri’s research is focused on understanding the molecular mechanisms underlying vascular calcification, a condition that contributes to cardiovascular diseases. His current studies explore gene therapies to treat vascular calcification in infants, as well as the role of histone deacetylases in vascular health. Additionally, his earlier work in Leishmaniasis has expanded his expertise to parasitology and cellular biology. His work bridges cardiovascular research and therapeutic innovation, offering potential treatments for critical vascular conditions. ❤️🧬

Conclusion

Lova Prasadareddy Kajuluri’s career is a testament to his commitment to advancing science in cardiovascular health and infectious diseases. Through his research, he continues to provide invaluable insights into vascular calcification and gene therapy, offering hope for future treatments in these fields. 🌟🔬

Publication Top Notes

Epigenetic Regulation of Human Vascular Calcification. Genes, 2025, 16, 506. DOI

Calponin 1 inhibits agonist-induced ERK activation and decreases calcium sensitization in vascular smooth muscle. Journal of Cellular and Molecular Medicine, January 28, 2024. PubMed

Treatment of calcific arterial disease via enhancement of autophagy using GSK343. iScience, October 28, 2023. PubMed

Intracellular localization of MyosinXXI discriminates Leishmania spp and Leptomonas seymouri. Biochemical and Biophysical Research Communications, May 14, 2022. PubMed

Actin-related protein 4: An unconventional negative regulator of mitochondrial calcium in protozoan parasite Leishmania. Mitochondrion, Jan 2022. PubMed

Vascular aging, the vascular cytoskeleton and aortic stiffness. Exploration of Medicine, June 2021. PubMed

The uterine myocyte, contractile machinery and proteins of the myometrium and their relationship to the dynamic nature of myometrial function. Current Opinion in Physiology, February 2020. ScienceDirect

A twinfilin-like protein coordinates karyokinesis by influencing mitotic spindle elongation and DNA replication in Leishmania. Molecular Microbiology, April 2016. PubMed

Oligomerization of coronin: Implication on actin filament length in Leishmania. Cytoskeleton (Hoboken, N.J.), December 2015. PubMed

Prof. Dr. Vicente Vanaclocha | Medicine | Lifetime achievement Award

Prof. Dr. Vicente Vanaclocha | Medicine | Lifetime achievement Award

Publication Profile

🎓 Education Background:

💼 Professional Experience:

🏅 Awards and Honors:

🔬 Research Focus:

📝 Conclusion:

📚 Top Publications: